• Talabostat Mesylate: From DPP4 to Translational Design

  2026-08-22

  Talabostat mesylate, also known as PT-100 or Val-boroPro, offers translational researchers a way to connect DPP4 and FAP inhibition with immune, stromal, and hematopoietic readouts. This thought-leadership perspective explains how to design rigorous studies around target engagement, tumor-context biology, and the selectivity lessons emerging from DPP9 inflammasome research.

• Nonselective β-Blockers and Hematopoietic Recovery

  2026-08-22

  The reference study identifies a context-dependent effect of nonselective β-adrenergic blockade on hematopoietic regeneration after transplantation. By combining mouse transplant models with human allogeneic HCT data, it distinguishes carvedilol-associated impairment from the comparatively limited effect of β1-selective metoprolol and highlights transplant cell dose and GVHD prophylaxis as important modifiers.

• BicD and MAP7 Activate Drosophila Kinesin-1

  2026-08-21

  This preprint shows that BicD and MAP7 activate homodimeric Drosophila kinesin-1 through complementary mechanisms: BicD relieves motor autoinhibition, whereas MAP7 improves microtubule engagement and run length. The work provides a mechanistic framework for understanding how adaptor proteins and microtubule-associated proteins jointly regulate bidirectional cargo transport.

• Cy7 NHS Ester: Practical Labeling Workflow

  2026-08-20

  Cy7 NHS ester (SKU A8109) is a water-soluble, sulfonated near-infrared dye for labeling accessible amino groups on proteins, peptides, and related biomolecules. It is suited to near-infrared fluorescent imaging and live-cell or in vivo tracking workflows, but not to experiments requiring long-term storage of prepared dye solutions or detection systems that cannot support its near-infrared wavelengths.

• Biotin (Vitamin B7, Vitamin H) in Cell Assays

  2026-08-20

  A scenario-based guide to using Biotin (Vitamin B7, Vitamin H), SKU A8010, in viability, proliferation, cytotoxicity, and protein-labeling workflows. It emphasizes solvent compatibility, metabolic interpretation, assay controls, and practical vendor selection without overstating what free biotin can achieve.

• (1S,3R)-RSL3 Glutathione Peroxidase 4 Inhibitor

  2026-08-19

  Build reproducible ferroptosis assays with RSL3 by combining GPX4 inhibition, lipid-peroxidation readouts, and mechanism-specific rescue controls. The workflow also helps distinguish ferroptotic killing from the apoptosis-linked RNA Pol II response described in recent Cell research.

• HyperPFU™ High-Fidelity DNA Polymerase Guide

  2026-08-19

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is suitable for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or sticky-end generation.

• G-1: Designing Selective GPR30 Signaling Assays

  2026-08-18

  G-1 is a selective GPR30 agonist for separating rapid GPER1 signaling from classical estrogen-receptor activity. This guide translates mechanistic evidence into practical assay design for immune, cardiovascular, and cancer research.

• GlycoRNA–csRBP Domains Guide TAT Entry

  2026-08-18

  This preprint expands the concept of the cell surface by identifying organized domains containing glycoRNAs and cell-surface RNA-binding proteins. Its perturbation experiments connect these domains to TAT cell entry, suggesting that extracellular RNA–protein organization can regulate communication with cell-penetrating peptides.

• JHU-083 and the Logic of Glutaminase Assays

  2026-08-17

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor that enables causal interrogation of glutaminase activity in cerebral immune-cell models. This article develops an assay-centered framework connecting glutamate measurements, redox biology, and the limitations of translating hepatotoxicity findings into neurological research.

• E-64 as a Lysoptosis Assay Probe

  2026-08-17

  E-64 provides a covalent, irreversible approach to cysteine protease inhibition and a practical way to test cathepsin-dependent lysosomal cell death. This article connects its biochemical selectivity with lysoptosis assay design, helping researchers distinguish lysosomal membrane damage from downstream proteolytic execution.

• GlycoRNA–RBP Nanodomains Enable TAT Entry

  2026-08-16

  This preprint proposes that cell-surface RNA-binding proteins and glycoRNAs assemble into nanoclusters that function as interaction sites for the cell-penetrating peptide TAT. Its perturbation experiments connect extracellular RNA organization with peptide internalization, broadening the functional definition of the plasma membrane beyond conventional transmembrane and lipid-anchored proteins.

• Acridine Orange hydrochloride Protocol Guide

  2026-08-15

  Acridine Orange hydrochloride provides a practical fluorescence-based approach for distinguishing nucleic-acid-associated green and red signals in cells and organelles. This dossier-grounded guide supports assay planning and QC, but it does not establish a universal staining concentration, incubation time, apoptosis diagnosis, or clinical application.

• ML133 HCl for Kir2.1 Research

  2026-08-14

  ML133 HCl is a selective potassium channel inhibitor for isolating Kir2.1-dependent effects in pulmonary vascular and cardiovascular ion channel research. This workflow translates published PASMC findings into practical dose design, migration assays, pathway validation, and troubleshooting steps.

• Cytarabine as a Lens on Cell Death Biology

  2026-08-14

  Cytarabine and AraC are more than DNA synthesis inhibitors: they provide a controllable apoptosis axis for separating replication stress from RIPK3-dependent necroptosis. This article connects leukemia assay design with the viral RIPK3-degradation mechanism reported in Immunity, while defining the limits of that cross-domain interpretation.

8395 records 1/560 page Next 12345 下5页 Last page